SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3ai62oF
via IFTTT